Kathryn Watts
Registered Nurse · Annapolis, MDNPI 1790098853
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among registered nurse clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$843
- Bayer$561
- Astellas Pharma US Inc$556
- Dendreon Pharmaceuticals LLC$550
- Pfizer$452
- Johnson & Johnson$358
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,23298%
- Education$1152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 34 | $843 |
| Bayer | 26 | $561 |
| Astellas Pharma US Inc | 26 | $556 |
| Dendreon Pharmaceuticals LLC | 21 | $550 |
| Pfizer | 24 | $452 |
| Johnson & Johnson | 21 | $358 |
| Ferring Pharmaceuticals Inc. | 21 | $305 |
| Progenics Pharmaceuticals, Inc. | 7 | $170 |
| Endo Pharmaceuticals Inc. | 8 | $145 |
| Myovant Sciences Inc. | 7 | $143 |
| Axonics, Inc. | 2 | $124 |
| Blue Earth Diagnostics | 5 | $123 |
| Tolmar Pharmaceuticals, Inc. | 5 | $122 |
| Accord Healthcare, Inc. | 5 | $110 |
| Urovant Sciences Inc | 5 | $110 |
| AstraZeneca | 4 | $102 |
| Merck | 4 | $82 |
| Endo USA, Inc. | 4 | $72 |
| Urogen Pharma, Inc. | 3 | $71 |
| AbbVie | 3 | $66 |
| Tolmar, Inc. | 2 | $58 |
| Innovation Technologies Inc | 1 | $48 |
| Vertex | 3 | $45 |
| Tempus AI, Inc | 1 | $30 |
| Novartis | 1 | $28 |
| Immunitybio, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
How this compares
$5,347 in reported general payments places this provider in the 95th percentile of 89 registered nurse providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 79 | $79,961 |
| MyrbetriqMirabegron | 58 | $60,849 |
| Tamsulosin Hcl | 204 | $5,993 |
| Estradiol | 57 | $4,823 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 44 | $1,532 |
| NitrofurantoinNitrofurantoin Macrocrystal | 30 | $1,309 |
| Methenamine Hippurate | 17 | $1,130 |
| Trimethoprim | 22 | $1,063 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 88 | $1,045 |
| Cephalexin | 67 | $823 |
| Finasteride | 37 | $796 |
| Alendronate Sodium | 28 | $494 |
| CefuroximeCefuroxime Axetil | 54 | $479 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 52 | $423 |
| Ciprofloxacin Hcl | 46 | $188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $843 | $79,96179 claims |
| Astellas Pharma US IncMyrbetriq | $556 | $60,84958 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 89 registered nurse providers in Maryland.
Other registered nurse in Annapolis
- Ashley NickellAnnapolis$125
- Tomeeka HawthorneColumbia$9K
- Denise WilsonLavale$6K
- Jennifer HubbardRandallstown$4K
- Amy SmithBel Air$4K
- Lindsay BlairBaltimore$2K
- Rachael FornwaltColumbia$1K
- Michele BrownBel Air$1K
- Lou BartoloChevy Chase$695
- Margaret CloughBaltimore$635
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.